Pathology of mammary glands in women with reproductive disorders and chronic endometritis

Background. The last decades are devoted to the search for various factors leading to the development of benign breast diseases, which are the risk of breast cancer. In gynecological diseases, the frequency of benign processes in the mammary glands increases to 76-97.8 %. Aims: this research is devoted to the study of the prevalence and structure of breast pathology in women with chronic endometritis and reproductive disorders. Materials and methods. The study included patients with reproductive disorders: 50 patients with histological verification of the diagnosis of chronic endometritis and 50 patients without chronic endometritis. Hormonal examination was carried out using radioimmunoassay and immunoenzymatic methods. Methods of mathematical statistics implemented Statistica 6.1 (USA) were used parametric criteria: Student's t-test and Fisher's F-criterion, the nature of the distribution was estimated using the methods of Kolmogorov - Smirnov with a significance level smaller and equal to 5 % (p < 0.05). To confirm the fact that the observed differences between the products of A x D and B x C are not random, we used the х2 criterion. Results and conclusions. In women with chronic endometritis, the pathology of the mammary glands is characterized by the presence of ectasia of the ducts of the mammary gland; clinically, it is manifested by lactorrhea. Benign dysplasia of mammary glands is accompanied by the presence of hyperestrogenia, hypoprogesteronemia, which is typical for ovarian dysfunction. It is possible to use a pathogenetically reasonable combination correction: anti-inflammatory therapy and the use of gestagens in women with reproductive disorders and chronic endometritis.

chronic endometritis, reproductive disorders, mammary glands, hormones

1. Высоцкая И.В., Погодина Е.М., Гладилина И.А. Клиническая маммология: Практическое руководство / Под ред. М.И. Давыдова, В.П. Летягина. - М., 2010. - С. 54-56

2. Гинекология: национальное руководство / Под ред. Г.М. Савельевой, Г.Т. Сухих, И.Б. Манухина. - М.: ГЭОТАР-Медиа, 2013. - 704 с

3. Данусевич И.Н. Состояние эндокринной и иммунной систем у женщин с хроническим эндометритом и репродуктивными нарушениями // Фундаментальные исследования. - 2013. - № 8. - С. 45-51

4. Данусевич И.Н., Козлова Л.С., Сутурина Л.В. Показатели иммунного статуса у пациенток с хроническим эндометритом // Проблемы репродукции. -2010. - С. 181

5. Дизрегуляционная патология: руководство для врачей и биологов / Под ред. Г.Н. Крыжановского. - М.: Медицина, 2002. - 632 с

6. Коган И.Ю., Мясникова М.О. Диагностика и лечение мастопатии. - СПб., 2010. - 32 с

7. Ледина А.В., Прилепская В.Н. Масталгия: клиника, диагностика, лечение // Гинекология. - 2011. -№ 5. - С. 66-76

8. Мустафин Ч.К., Кузнецова С.В. Дисгормональ-ные болезни молочной железы. Клиническое руководство / Под ред. Е.Г. Пинхосевича. - М., 2009. - 126 с

9. Рожкова Н.И., Бурдина И.И., Меских Е.В. Диффузные доброкачественные заболевания молочной железы. Диагностика и лечение / Под ред. В.А. Солодкого, Н.И. Рожковой. - М.: СИМК, 2012. - 124 с

10. Реброва О.Ю. Статистический анализ медицинских данных // Применение пакета прикладных программ STATISTICA. - 2003. - 305 с

11. Харченко В.П., Рожкова Н.И. Национальное руководство по маммологии. - М.: ГЭОТАР-Медиа, 2006. - 361 с

12. Belokrinitskaya T., Popova L., Suturina L., Grebenkina L. (2012). The dynamics of reduced/oxygenized glutathione ratio in women with benign breast disease after 3 months usage of herbal medicine mastodynon. Giornale Italiano di Ostetricia e Ginecologia, 7-10 marzo, 48.

13. Iddon J., Dixon JM. (2013). Mastalgia. BMJ, 347, f3288.

14. Kataria K., Dhar A., Srivastava A. (2014). A systematic review of current understanding and management of mastalgia. Indian J Surg, 76 (3), 217-222. DOI: 10.1007/s12262-013-0813-8

15. Mansel R.E., Webster D.J.T., Sweetland H.M. (2009). Breast pain and nodularity. Saunders Elsevier, 107-138.

16. Onstad M., Stuckey A. (2013). Benign breast disorders. Obstet Gynecol Clin North A.M., 40 (3), 459-473. DOI: 10.1016/j.ogc.2013.05.004

17. Russo J. (2015). Significance of rat mammary tumors for human risk assessment. Toxicol Pathol, 43 (2), 145-170. DOI: 10.1177/0192623314532036

18. Socolov D., Anghelache I., Ilea C., Socolov R., Carauleanu A. (2015). Benign breast disease and the risk of breast cancer in the next 15 years. Rev Med Chir Soc Med Nat Iasi, 119 (1), 135-140.

19. Skarda J. (2002). Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. Physiol Res, 51 (3), 267-276.